Wolf Haldenstein Adler Freeman & Herz LLP announces that it is investigating Verve Therapeutics, Inc. for potential violations of federal securities laws

April 19, 2024

https://www.prnewswire.com/news-releases/wolf-haldenstein-adler-freeman–herz-llp-announces-that-it-is-investigating-verve-therapeutics-inc-for-potential-violations-of-federal-securities-laws-302121755.html

NEW YORK, April 19, 2024 /PRNewswire/ — Wolf Haldenstein Adler Freeman & Herz LLP (“Wolf Haldenstein“), a preeminent national shareholder rights litigation firm, announces that it is investigating claims
on behalf of investors of Verve Therapeutics, Inc. (“Verve” or “the Company”) (NASDAQ:VERV) for violations of the securities laws.

Read more at prnewswire.com

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.